+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Fecal Incontinence Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767471
  • Report
  • April 2019
  • Region: Global
  • 70 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Anterogen Co Ltd
  • Assembly Biosciences Inc
  • BioKinetic Europe Ltd
  • Cook Medical Inc
  • Dianthus Medical Limited
  • Epworth HealthCare
  • MORE
The global clinical trial report- “2019 Fecal Incontinence Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Fecal Incontinence. It presents in-depth analysis of Fecal Incontinence clinical trials across markets and companies. The research work is for providing complete understanding into trends in Fecal Incontinence.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Fecal Incontinence clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Fecal Incontinence

The research work is prepared through extensive and continuous research on Fecal Incontinence trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Fecal Incontinence patients are identified
  • The report includes panorama of Fecal Incontinence clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Fecal Incontinence clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Anterogen Co Ltd
  • Assembly Biosciences Inc
  • BioKinetic Europe Ltd
  • Cook Medical Inc
  • Dianthus Medical Limited
  • Epworth HealthCare
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Fecal Incontinence Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Fecal Incontinence Clinical Trials by Region
2.2.2 Average Enrollment of Fecal Incontinence Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Fecal Incontinence Treatment, 2019

3. Region wise Fecal Incontinence Clinical Trials
3.1 Asia Pacific Fecal Incontinence Clinical Trials by Country
3.2 Europe Fecal Incontinence Clinical Trials by Country
3.3 North America Fecal Incontinence Clinical Trials by Country
3.4 Middle East and Africa Fecal Incontinence Clinical Trials by Country
3.5 South and Central America Fecal Incontinence Clinical Trials by Country

4. Fecal Incontinence Clinical Trial Trends
4.1 Start Year wise Fecal Incontinence Clinical Trials
4.2 Phase wise Fecal Incontinence Clinical Trials
4.3 Trial Status wise Fecal Incontinence Clinical Trials
4.4 Trial Type wise Fecal Incontinence Clinical Trials

5. Fecal Incontinence Average Enrollment Trends
5.1 Average Enrollment in Fecal Incontinence Trials by Year
5.2 Average Enrollment in Fecal Incontinence Trials by Phase
5.3 Average Enrollment in Fecal Incontinence Trials by Status
5.4 Average Enrollment in Fecal Incontinence Trials by Type of Trial

6. Companies Participating in Fecal Incontinence Clinical Trials
6.1 Fecal Incontinence Trials by Sponsor Type
6.2 Fecal Incontinence Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Fecal Incontinence Trials- Phase 1
7.2 Fecal Incontinence Trials- Phase 2
7.3 Fecal Incontinence Trials- Phase 3
7.4 Fecal Incontinence Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Fecal Incontinence Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Fecal Incontinence Clinical Trials and Enrolment
Figure 5: Europe - Country wise Fecal Incontinence Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Fecal Incontinence Clinical Trials and Enrolment
Figure 7: North America - Country wise Fecal Incontinence Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Fecal Incontinence Clinical Trials and Enrolment
Figure 9: Fecal Incontinence Clinical Trials by Phase
Figure 10: Fecal Incontinence Clinical Trials by Trial Status
Figure 11: Fecal Incontinence Clinical Trials by Type
Figure 12: Fecal Incontinence Clinical Trials by Sponsor Type
Figure 13: Fecal Incontinence Clinical Trials by Leading Sponsors
Figure 14: Fecal Incontinence Average Enrollment by Phase
Figure 15: Fecal Incontinence Average Enrollment by Trial Status
Figure 16: Fecal Incontinence Average Enrollment by Type
Figure 17: Fecal Incontinence- Average Enrolment by Type of Sponsors
Figure 18: Fecal Incontinence- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Fecal Incontinence Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Fecal Incontinence Clinical Trials and Enrolment
Table 5: Europe - Country wise Fecal Incontinence Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Fecal Incontinence Clinical Trials and Enrolment
Table 7: North America - Country wise Fecal Incontinence Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Fecal Incontinence Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Fecal Incontinence Average Enrollment by Phase
Table 15: Fecal Incontinence Average Enrollment by Trial Status
Table 16: Fecal Incontinence Average Enrollment by Type
Table 17: Fecal Incontinence- Average Enrolment by Type of Sponsors
Table 18: Fecal Incontinence- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • Anterogen Co Ltd
  • Assembly Biosciences Inc
  • BioKinetic Europe Ltd
  • Cook Medical Inc
  • Dianthus Medical Limited
  • Epworth HealthCare
  • GlaxoSmithKline Plc
  • Innovacell Biotechnologie AG
  • Norgine BV
  • RDD Pharma Ltd
Note: Product cover images may vary from those shown
Adroll
adroll